Medical Equipment

Lateral Flow Assays Market Growth Expected To Reach $19.3 Billion By 2030 At 9.5% CAGR

April 14, 2026April 14, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Lateral Flow Assays Market Compare Between 2026 And 2030?

The lateral flow assays market has demonstrated strong expansion recently. It is anticipated to increase from $12.29 billion in 2025 to $13.45 billion in 2026, progressing at a compound annual growth rate (CAGR) of 9.4%. The factors contributing to its growth in previous periods include a heightened demand for rapid diagnostic solutions, the broader scope of infectious disease testing, the widespread adoption of rapid test kits, the expansion of decentralized healthcare delivery, and increasing awareness of early disease detection.

The lateral flow assays market size is projected to experience substantial expansion in the coming years, reaching a valuation of $19.3 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.5%. This projected growth during the forecast period is fueled by several factors, including the rising acceptance of home-based diagnostic solutions, broader incorporation of digital health technologies, an increasing need for multiplex testing, greater capital expenditure in swift diagnostic innovations, and an intensified focus on continuous disease tracking. Key trends anticipated over this period encompass the wider utilization of quick point-of-care diagnostics, the growing prevalence of multiplex lateral flow assays, enhanced embedding of digital lfa readers, the extension of testing into veterinary and home settings, and a heightened emphasis on improving test sensitivity.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/lateral-flow-assays-global-market-report

Which Key Factors Are Driving The Lateral Flow Assays Market Growth?

The widespread occurrence of infectious diseases globally is a major factor driving the expansion of the lateral flow assay market. In developing nations, the frequent incidence of diseases like HIV and malaria, coupled with insufficient healthcare infrastructure and increasing public understanding, is expected to boost the uptake of lateral flow assay testing. The recent COVID-19 pandemic underscored the critical importance of early disease detection, which is anticipated to further propel market growth. A clear example of this trend is seen in England, where in August 2024, data from the UK Health Security Agency (UKHSA), a UK-based executive agency, revealed 368 measles cases in 2023. This figure represents an almost sevenfold surge compared to the 53 cases reported in 2022, with the West Midlands and London contributing 44% and 33% of these cases, respectively. Consequently, the significant prevalence of infectious diseases worldwide is set to fuel the growth of the lateral flow assay market.

What Segment Categories Shape The Lateral Flow Assays Market Segment Landscape?

The lateral flow assays market covered in this report is segmented –

1) By Type: Kits And Reagents, Lateral Flow Readers

2) By Technique: Sandwich Assays, Competitive Assays, Multiplex Detection Assays

3) By Application: Veterinary Diagnostics, Clinical Or Point-Of-Care Testing, Drug Development And Quality Testing, Other Applications

4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Home Care Settings, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Kits And Reagents: Rapid Test Kits, Diagnostic Kits, Control Reagents, Sample Collection And Preparation Reagents

2) By Lateral Flow Readers: Portable Lateral Flow Readers, Benchtop Lateral Flow Readers, Smartphone-Based Lateral Flow Readers, Automated Lateral Flow Readers

Which Trends Are Guiding The Direction Of The Lateral Flow Assays Market?

Leading companies within the lateral flow assay market are concentrating on developing adaptable products, such as lateral flow readers, to enable convenient on-the-go testing and secure a competitive edge. A lateral flow reader functions as a portable instrument, performing rapid and qualitative analysis of lateral flow assays to deliver effective results across diverse testing scenarios. For instance, in February 2024, Upfront Diagnostics, a healthcare firm based in the UK, introduced the Lateral Flow Test for Triaging Stroke Patients Next Year. This specific test, known as LVOne, is engineered for triaging stroke patients with the goal of significantly enhancing the speed and precision of stroke diagnosis outside of hospitals. The LVOne test involves a rapid blood analysis, allowing paramedics to detect strokes resulting from large vessel occlusions (LVO) within a quarter of an hour. Such swift identification is critical for expediting patient transfer to specialized stroke facilities where prompt medical intervention can drastically improve recovery and minimize enduring disabilities.

Who Are The Companies Operating Across The Lateral Flow Assays Market Value Chain?

Major companies operating in the lateral flow assays market are Siemens AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Hologic Inc., BioMérieux SA, PerkinElmer Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Roche Holding AG, QIAGEN N.V., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Molbio Diagnostics, Trinity Biotech, Chembio Diagnostics Inc., Coris BioConcept, HYCOR Biomedical, Diagnostic BioSystems GmbH, Express Diagnostics Ltd., Fujirebio Diagnostics Inc., Innova Diagnostics Inc., Leadtec Diagnostics Inc., S&D Diagnostics Inc., Standard Diagnostics Inc., V-Chek Diagnostics

Get The Full Lateral Flow Assays Market Report:

https://www.thebusinessresearchcompany.com/report/lateral-flow-assays-global-market-report

Which Region Leads The Lateral Flow Assays Market In Overall Market Size?

North America was the largest region in the lateral flow assays market in 2025. Asia-Pacific is expected to be the fastest-growing region in the lateral flow assays market share during the forecast period. The regions covered in the lateral flow assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Lateral Flow Assays Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/lateral-flow-assays-global-market-report

Browse Through More Reports Similar to the Global Lateral Flow Assays Market 2026, By The Business Research Company

Lateral Flow Immunoassay Based Rapid Test Market Report 2026

https://www.thebusinessresearchcompany.com/report/lateral-flow-immunoassay-based-rapid-test-global-market-report

Flow Meter Market Report 2026

https://www.thebusinessresearchcompany.com/report/flow-meter-global-market-report

Flow Chemistry Market Report 2026

https://www.thebusinessresearchcompany.com/report/flow-chemistry-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795